ImmunologybioRxiv
Nanobody-mediated Complement Activation to Kill HIV-infected Cells
M. L. Pedersen, D. V. Pedersen, M. B. L. Winkler…·M. Tolstrup
This paper develops a bispecific complement engager to target HIV-1-infected cells, enhancing complement-mediated killing through C3 deposition and CDC.
DOI 10.15252/emmm.202216422